Monday, 24 Feb 2020

You are here

Linkage Between Gut and Joint Immunity in Rheumatoid Arthritis

Pianta, et al have published their findings in the Journal of Clinical Investigation showing that two novel autoantigens, GNS and FLNA, are highly expressed in synovium and share a sequence homology with gut microbesa; thereby providing a potential link between gut mucosal and joint immunity in rheumatoid arthritis (RA). 

Researchers used discovery-based proteomics to detect HLA-DR–presented peptides in synovia or peripheral blood mononuclear cells from RA patients. They found that two autoantigens, N-acetylglucosamine-6-sulfatase (GNS) and filamin A (FLNA), yielded effective T and B cell antigen specific responses (52% and 56%, respectively).

GNS and FLNA are highly expressed in synovia. GNS appeared to be citrullinated, and GNS antibody values correlate with ACPA levels. FLNA was different and did not show the same results.

The GNS peptide has marked sequence homology with epitopes from Prevotella sp. and Parabacteroides sp.

FLNA peptide has homology with epitopes from Prevotella sp. and Butyricimonas sp.

Reactivity to either GNS or FLNA was associated with reactivity to the corresponding microbial peptides.

Also, binding of these self- and microbial peptides and their responses were more common in RA patients with SE alleles.

The homology and cross reactivity of these two self-proteins and corresponding gut microbes may provide a link between mucosal and joint immunity in patients with RA.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Seronegativity on the Rise in RA

Although the overall incidence rates of rheumatoid arthritis (RA) have remained stable over recent decades, there has been a significant increase in seronegative cases, a retrospective study showed.

Alcohols Net Zero Effect in Rheumatoid Arthritis

A report from The National Databank for Rheumatic Disease addressed the impact of alcohol on disease activity and mortality in rheumatoid arthritis (RA) and found that alcohol use was not associated with changes in disease activity or mortality, after addressing confounders. 

DMARD Inertia by Registry Rheumatologists

A registry study of metric use (primarily RAPID3 and CDAI) in the treatment of rheumatoid arthritis (RA) patients shows that, even in the face of moderate or high disease activity, treatment changes by rheumatologists were relatively low (35.6–54.6%).

Bariatric Weight Loss Fails to Alter RA Risk

Obesity has been shown to be a risk factor for the onset of rheumatoid arthritis (RA) and also shown to affect outcomes by impairing responses to many DMARD therapies. A Swiss study of RA patients undergoing bariatric surgery failed to show that bariatric surgery and weight loss had any effect on the incidence of RA.

Limited Advantage to Very Early vs. Delayed Etanercept in RA

The VEDERA study sought to confirm whether the very early introduction of first-line etanercept+methotrexate (ETN+MTX) was superior to treat-to-target MTX (MTX-TT) in patients with early RA.